EP Patent

EP1071658B1 — Btk inhibitors and methods for their identification and use

Assigned to Parker Hughes Institute · Expires 2004-06-16 · 22y expired

What this patent protects

The invention provides BTK inhibitors, methods for their identification and use, and pharmaceutical compositions comprising BTK inhibitors.

USPTO Abstract

The invention provides BTK inhibitors, methods for their identification and use, and pharmaceutical compositions comprising BTK inhibitors.

Drugs covered by this patent

Patent Metadata

Patent number
EP1071658B1
Jurisdiction
EP
Classification
—
Expires
2004-06-16
Drug substance claim
No
Drug product claim
No
Assignee
Parker Hughes Institute
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.